24 participants
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2013-07-22
- Start Date:
- 2007-08-31
- Completion:
- 2011-01-31
Conditions
- Corneal Neovascularization
Interventions
- DRUG